Showing results (1481-1490 of 1,729) with videos related to
Sort By:
Pageof 173
Neuropathology and Applied Neurobiology|December 15, 2022
Analysing cerebrospinal fluid with explainable deep learning: From diagnostics to insightsLeonille Schweizer, Philipp Seegerer, Hee-Yeong Kim, et al.British Journal of Cancer|September 1, 2011
Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohortR Y Zang, P Harter, D S Chi, et al.JCO Precision Oncology|June 12, 2026
Constitutional BRCA1 Promoter Methylation in Patients With Ovarian Cancer: Results of the Observational AGO-TR1 StudyMohamad Kayali, Eric Hahnen, Alexander Burges, et al.Journal of Physical Activity & Health|January 22, 2026
Changes in Leisure-Time Physical Activity and All-Cause Mortality in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)Samuel C Dumith, Natan Feter, Danilo de Paula, et al.Scientific Reports|February 4, 2015
Identification of flubendazole as potential anti-neuroblastoma compound in a large cell line screenMartin Michaelis, Bishr Agha, Florian Rothweiler, et al.Gynecologic Oncology|October 18, 2025
Development and optimization of an integrated exercise and nutrition program for ovarian cancer patients: Phase I of the BENITA multi-center studyTabea Maurer, Matthias H Belau, Birgit-Christiane Zyriax, et al.Nature Communications|October 24, 2017
Organic coating on biochar explains its nutrient retention and stimulation of soil fertilityNikolas Hagemann, Stephen Joseph, Hans-Peter Schmidt, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 1, 2019
European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer SurgeryDenis Querleu, François Planchamp, Luis Chiva, et al.Gynecologic Oncology|November 24, 2018
Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12F Heitz, P Harter, E Åvall-Lundqvist, et al.Gynecologic Oncology|March 2, 2021
Age, treatment and prognosis of patients with squamous cell vulvar cancer (VSCC) - analysis of the AGO-CaRE-1 studyKatharina Prieske, Linn Woelber, Mustafa Zelal Muallem, et al.Pageof 173